TEGRETOL SUSPENSION
NOVARTIS PHARMACEUTICALS CANADA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of TEGRETOL SUSPENSION in Canada?
A shortage of TEGRETOL SUSPENSION 100MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 24, 2026), but it has not started yet.
Why is TEGRETOL SUSPENSION not available?
The reason the manufacturer reported: Demand increase for the drug.
When will TEGRETOL SUSPENSION be available again?
The manufacturer's estimated resolution date is November 13, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
SANDOZ-CARBAMAZEPINE CHEWTABS
SANDOZ CANADA INCORPORATED
PMS-CARBAMAZEPINE
PHARMASCIENCE INC
TEGRETOL
NOVARTIS PHARMACEUTICALS CANADA INC
TEGRETOL CR
NOVARTIS PHARMACEUTICALS CANADA INC
NU-CARBAMAZEPINE TAB 200MG
NU-PHARM INC
CARBAMAZEPINE 200 TAB 200MG
PRO DOC LIMITEE
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2026-11-13
~2 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02194333
Strength
100MG
Dosage Form
SUSPENSION
Route
ORAL
Active Ingredient
CARBAMAZEPINE
Tier
Unrated
Last Updated
2026-09-24
Reason for Shortage
Demand increase for the drug.
Other Products from NOVARTIS PHARMACEUTICALS CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
2.5MG · DIN 02369257
10MG · DIN 02339528
5MG · DIN 02339501
7.5MG · DIN 02450267
2MG · DIN 02425645
5MG · DIN 02425661
3MG · DIN 02425653
140MG · DIN 02487306
70MG · DIN 02479613
0.1% · DIN 00893560
100MG · DIN 02381559
1000MG · DIN 02381567